Attached files
| file | filename |
|---|---|
| 8-K - FORM 8-K - Capstone Therapeutics Corp. | f8k_030416.htm |
Exhibit 16.1
March 4, 2016
Securities and Exchange Commission
100 F Street, N.E.
Washington, D.C. 20549-6561
Ladies and Gentlemen:
We have read Item 4.01 of Form 8-K dated February 29, 2016 of Capstone Therapeutics Corp. (the “Company”) and are in agreement with the statements contained therein, except that we are not in a position to agree or disagree with the Company’s statement in paragraph 1 that the Company’s Board of Directors initiated and approved the decision to not authorize us to commence the audit of the Company’s 2015 consolidated financial statements.
Respectfully,
/s/ Moss Adams LLP